Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00136084 · ClinicalTrials.gov registry record · Phase 3
Treatment of Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplasia
A Phase 3 study, sponsored by St. Jude Children's Research Hospital.
- Completed
- Registry status
- Phase 3
- Development phase
- 238
- Enrollment target
NCT00136084 is a Phase 3 study that has completed, run by St. Jude Children's Research Hospital. The registered enrollment target is 238 participants.
The verdict
NCT00136084, a Phase 3 study, has completed, sponsored by St. Jude Children's Research Hospital.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 238 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the effectiveness of two multi-agent chemotherapy regimens using different dosages of cytarabine to eliminate all detectable leukemia.
Interventions
- DRUG Cladribine, Cyclophosphamide, Cytarabine, Daunorubicin, Dexamethasone
- DRUG Etoposide, Cytarabine, Gemtuzumab, L-asparaginase, Mercaptopurine, methotrexate, Mitoxantrone, Prednisone, Vincristine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 238 participants |
| Start Date | 2002-08 |
| Est. Completion | 2012-06 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00136084
The ClinicalTrials.gov registry entry for NCT00136084 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 238 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is St. Jude Children's Research Hospital, which has 410 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Cladribine, Cyclophosphamide, Cytarabine, Daunorubicin, Dexamethasone is the first listed.
NCT00136084 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00136084 about?
NCT00136084 is a clinical study titled "Treatment of Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplasia". The purpose of this study is to compare the effectiveness of two multi-agent chemotherapy regimens using different dosages of cytarabine to eliminate all detectable leukemia.
What is the current status of trial NCT00136084?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 238 participants. The study started on 2002-08. Estimated completion is 2012-06.
What interventions are being tested in trial NCT00136084?
The interventions under investigation include: Cladribine, Cyclophosphamide, Cytarabine, Daunorubicin, Dexamethasone (DRUG), Etoposide, Cytarabine, Gemtuzumab, L-asparaginase, Mercaptopurine, methotrexate, Mitoxantrone, Prednisone, Vincristine (DRUG).
Who is sponsoring clinical trial NCT00136084?
This trial is sponsored by St. Jude Children's Research Hospital, which has 410 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.